TRANSMEDICS GROUP INC - NOTE 1.500% 6/0

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Debt / NOTE 1.500% 6/0
Market price (% of par)
175.55%
Total 13F principal
$452,711,000
Principal change
+$447,211,000
Total reported market value
$796,245,316
Number of holders
39
Value change
+$786,600,070
Number of buys
38

Institutional Holders of TRANSMEDICS GROUP INC - NOTE 1.500% 6/0 as of Q2 2024

As of 30 Jun 2024 TRANSMEDICS GROUP INC - NOTE 1.500% 6/0 had 39 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of $452,711,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Linden Advisors LP, READYSTATE ASSET MANAGEMENT LP, MACKAY SHIELDS LLC, WOLVERINE ASSET MANAGEMENT LLC, LAZARD ASSET MANAGEMENT LLC, Sculptor Capital LP, Man Group plc, Voya Investment Management LLC, STATE STREET CORP, and CAPSTONE INVESTMENT ADVISORS, LLC.
This table shows 39 bond principal holders of the security as of 30 Jun 2024.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.